N'-(3,4-dimethoxybenzylidene)-4-methylbenzenesulfonohydrazide derivatives: Synthesis, quantum chemical method, in silico ADMET, molecular docking and molecular dynamic simulations

•Novel synthesis of N'-(3,4-dimethoxybenzylidene)−4-methylbenzenesulfonohydrazide derivatives.•New compound is conveniently characterized by IR and NMR spectral techniques.•NBO, MEP, NLO and HOMO-LUMO analysis have been studied.•Molecular Docking, molecular dynamic simulations and ADMET studies were carried out. A new N'-(3,4-dimethoxybenzylidene)-4-methylbenzenesulfonohydrazide derivatives were prepared from a condensation reaction between 4-methylbenzenesulfonohydrazide and 3,4-dimethoxybenzaldehyde. The structure of DMSH was elucidated using various spectral techniques including FT-IR, 1HNMR and 13CNMR. The structure of DMSH bond parameters also confirmed by single crystal XRD analysis of related derivatives and optimized bond parameters are calculated by density functional theory (DFT) method at B3LYP/6–311 G (d, p) level of theory. The optimized geometrical parameters obtained by DFT calculation are in good agreement with single crystal XRD data. The experimentally observed FT-IR bands were assigned to different normal modes of the molecule. The results show a good agreement with each other when these computed bond parameters are compared to XRD values of related compounds. The stability, chemical reactivity and charge transfer within the molecule was explained by frontier molecular orbital calculations. Atomic charges on the various atoms of DMSH obtained by Mulliken population analysis. Potential reactive sites of the DMSH compound have been identified by MEP which is mapped to the electron density surfaces. The reported molecule is used as a potential NLO material since it has a high μβ0 value. The theoretical UV–vis spectrum of the compound is used to study the visible absorption maxima (λ max). The molecular docking mechanism between DMSH ligand and COVID-19/6WCF and COVID-19/6Y84 receptors were studied to investigate the binding modes of this compound at the active sites. Molecular docking outcomes have shown that the DMSH molecule can be considered as a potential agent against COVID-19/6WCF-6Y84 receptors. In addition, the theoretical parameters of the bioactive molecules were calculated to establish their drug-likeness qualities and ADME/T analysis was carried out to examine the drug properties of the synthesized compound. Molecular dynamics simulation was performed for COVID-19 main protease (Mpro: 6WCF/6Y84) to understand the elements governing the inhibitory effect and the stability of interaction under dynamic conditions. The resultant com